153 related articles for article (PubMed ID: 35028315)
1. Correlation Analysis of Acute Coronary Syndrome with Serum IL-18, MMP-9, hs-CRP, and Plasma FIB.
Yang Y; Li G; Zhang R
Biomed Res Int; 2022; 2022():5984184. PubMed ID: 35028315
[TBL] [Abstract][Full Text] [Related]
2. Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.
Li C; Zhang Z; Peng Y; Gao H; Wang Y; Zhao J; Pan C
PLoS One; 2019; 14(8):e0220841. PubMed ID: 31387110
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
[TBL] [Abstract][Full Text] [Related]
4. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
5. Expressions and clinical significance of factors related to acute coronary syndrome.
Sun H; Zhang J; Zheng Y; Shang S
J Biol Regul Homeost Agents; 2018; 32(2):299-305. PubMed ID: 29685010
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum high-sensitivity C-reactive protein and interleukin-6 in patients with acute coronary syndrome.
Wang XH; Liu SQ; Wang YL; Jin Y
Genet Mol Res; 2014 Jun; 13(2):4260-6. PubMed ID: 25036169
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9.
Guo C; Zhang S; Zhang J; Liu H; Li P; Liu H; Wang Y
Exp Ther Med; 2014 May; 7(5):1177-1180. PubMed ID: 24940407
[TBL] [Abstract][Full Text] [Related]
8. [Effects of naoxintong capsule on the inflammation and prognosis in borderline lesion coronary heart disease patients].
Li SR; Wang TH; Zhang BJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):607-11. PubMed ID: 22679718
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Xuezhikang on serum levels of high sensitive-C reactive protein, matrix metalloproteinase-9 and lipoprotein in patients with acute coronary syndrome].
Huang J; Wang MH; Peng XP; Wei C; Lu J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Mar; 26(3):221-3. PubMed ID: 16613266
[TBL] [Abstract][Full Text] [Related]
10. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
[TBL] [Abstract][Full Text] [Related]
11. [Associations between the plasma inflammatory markers and plaque morphologies of coronary artery lesions].
Wang X; Hu DY; Yang SW; Zhang J; Tan C; Zhang SY
Zhonghua Nei Ke Za Zhi; 2008 Jan; 47(1):27-30. PubMed ID: 18346322
[TBL] [Abstract][Full Text] [Related]
12. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
Allal-Elasmi M; Zayani Y; Zidi W; Zaroui A; Feki M; Mourali S; Mechmeche R; Kaabachi N
Clin Lab; 2014; 60(6):951-6. PubMed ID: 25016699
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inflammatory markers for the prediction of neointimal hyperplasia after drug-eluting stent implantation.
Kang WC; Il Moon C; Lee K; Han SH; Suh SY; Moon J; Shin MS; Ahn T; Shin EK
Coron Artery Dis; 2011 Dec; 22(8):526-32. PubMed ID: 21909023
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease.
Zeng B; Prasan A; Fung KC; Solanki V; Bruce D; Freedman SB; Brieger D
Intern Med J; 2005 Jun; 35(6):331-5. PubMed ID: 15892761
[TBL] [Abstract][Full Text] [Related]
15. [Intravascular ultrasound study of coronary remodeling and determination of matrix metalloproteinase and hypersensitive C-reactive protein].
Hui B; Dang Q; Wang XF; Jin Z; Xia DS; Gao L; Cai L; Zhang J; Xu F; Wang PX
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):428-32. PubMed ID: 15932701
[TBL] [Abstract][Full Text] [Related]
16. [The role of atherosclerotic plaque stability and inflammation in the pathogenesis of acute coronary syndrome].
Ding SF; Zhang Y; Zhang M; Chen WQ; Chen YG; Li JF; Ji QS; Li GS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jun; 34(6):512-4. PubMed ID: 16842667
[TBL] [Abstract][Full Text] [Related]
17. Investigation on Risk Stratification and the Prognostic Value of hs-TnT Combined with MMP-2 in Patients with Acute Coronary Syndrome.
Li Y; Li L; Wang K; Wu P; Cui Y
Biomed Res Int; 2021; 2021():1040171. PubMed ID: 34859099
[TBL] [Abstract][Full Text] [Related]
18. [Association of matrix metalloproteinase-9 and platelet membrane glycoprotein VI polymorphisms with acute coronary syndrome].
Qin Q; Zhao BR; Mao YM; Cui RZ; Kou L; Li YL; Zhao FM; Hui RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jul; 33(7):622-6. PubMed ID: 16080811
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
Ji Q; Zeng Q; Huang Y; Shi Y; Lin Y; Lu Z; Meng K; Wu B; Yu K; Chai M; Liu Y; Zhou Y
Mediators Inflamm; 2014; 2014():165742. PubMed ID: 24733959
[TBL] [Abstract][Full Text] [Related]
20. Correlation between Changes in Serum RBP4, hs-CRP, and IL-27 Levels and Rosuvastatin in the Treatment of Coronary Heart Disease.
Wang Y; Zhou C; Yu T; Zhao F
J Healthc Eng; 2021; 2021():8476592. PubMed ID: 34956579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
